The VICTUS Femtosecond Laser Platform, a project with Technolas Perfect Vision in Germany, does not yet have marketing approval. It is capable of supporting cataract, refractive and therapeutic procedures in a single platform.
The enVista glistening-free, hydrophobic acrylic IOL has received CE Mark approval in the European Union and is awaiting FDA approval. In addition to its glistening-free material, the lens is designed to minimize posterior capsular opacification, which causes vision to become clouded after surgery.
Related Articles on Technical Advances in Ophthalmology:
8 Key Technical Advances in Ophthalmology
Why Aren’t Surgery Centers Buying Femtosecond Lasers?
Technological Changes Affecting Eye ASCs: Q&A With Larry Patterson of Eye Centers of Tennessee
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
